Larimar Therapeutics, Inc. (LRMR)
3.81
-0.10
(-2.56%)
USD |
NASDAQ |
Dec 31, 16:00
3.70
-0.11
(-2.89%)
After-Hours: 20:00
Larimar Therapeutics EPS Diluted (Quarterly): -0.6092 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -47.71M |
| Total Expenses (Quarterly) | 47.71M |
| Enterprise Value | 155.01M |
| Earnings Yield | -50.59% |
| Normalized Earnings Yield | -50.59 |